LifeLens Technologies has filed a notice of an exempt offering of securities to raise $35 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, LifeLens Technologies is raising up to $35,000,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Brent Moen played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About LifeLens Technologies
LifeLens was founded in 2014 by Dr. Robert Schwartz, Landy Toth, David Robins, and Dr. Robert Van Tassel. Its mission is to create simple, commercially viable technologies for high fidelity physiologic monitoring. Since 2014, we have been quietly developing our breakthrough technologies that we believe will revolutionize physiologic monitoring for patients remotely and in the hospital. We combine our proprietary feather-weight patch and algorithms that we developed before Artificial Intelligence (AI) came into vogue, resulting in the only platform of its kind! For the past several years, we have been testing our system with the U.S. Military. Their personnel have put it through rigorous testing in extremely harsh conditions. Many report, “I forgot I was wearing it!” Medics and leadership like it as it helps keep the troops safe.
To learn more about LifeLens Technologies, visit http://www.lifelenstech.com/
LifeLens Technologies Linkedin Page: https://www.linkedin.com/company/lifelens-technologies-llc/
Contact:
Brent Moen, Chief Financial Officer
267-362-9362
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.